Louis Jacques Discusses New Drug Approvals and Reimbursement with Pink Sheet
ADVI's Louis Jacques, chief clinical officer, sat down with the Pink Sheet to discuss how FDA and CMS are working to ensure a smooth handoff from new drug approval to reimbursement.
September 15, 2022, ADVI’s Louis Jacques, chief clinical officer, sat down with the Pink Sheet to discuss how FDA and CMS are working to ensure a smooth handoff from new drug approval to reimbursement. Read the full article here.
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.